• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

代谢重编程:一种用于肺动脉高压的新型代谢模型。

Metabolic reprogramming: A novel metabolic model for pulmonary hypertension.

作者信息

Liu Xuhan, Zhang Liping, Zhang Weihua

机构信息

Department of Cardiovascular Medicine, The First Hospital of Jilin University, Changchun, China.

出版信息

Front Cardiovasc Med. 2022 Aug 26;9:957524. doi: 10.3389/fcvm.2022.957524. eCollection 2022.

DOI:10.3389/fcvm.2022.957524
PMID:36093148
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9458918/
Abstract

Pulmonary arterial hypertension, or PAH, is a condition that is characterized by pulmonary artery pressures above 20 mmHg (at rest). In the treatment of PAH, the pulmonary vascular system is regulated to ensure a diastolic and contraction balance; nevertheless, this treatment does not prevent or reverse pulmonary vascular remodeling and still causes pulmonary hypertension to progress. According to Warburg, the link between metabolism and proliferation in PAH is similar to that of cancer, with a common aerobic glycolytic phenotype. By activating HIF, aerobic glycolysis is enhanced and cell proliferation is triggered. Aside from glutamine metabolism, the Randle cycle is also present in PAH. Enhanced glutamine metabolism replenishes carbon intermediates used by glycolysis and provides energy to over-proliferating and anti-apoptotic pulmonary vascular cells. By activating the Randle cycle, aerobic oxidation is enhanced, ATP is increased, and myocardial injury is reduced. PAH is predisposed by epigenetic dysregulation of DNA methylation, histone acetylation, and microRNA. This article discusses the abnormal metabolism of PAH and how metabolic therapy can be used to combat remodeling.

摘要

肺动脉高压(PAH)是一种以静息时肺动脉压高于20 mmHg为特征的病症。在PAH的治疗中,肺血管系统会得到调节以确保舒张和收缩平衡;然而,这种治疗并不能预防或逆转肺血管重塑,仍会导致肺动脉高压进展。根据瓦尔堡的理论,PAH中代谢与增殖之间的联系类似于癌症,具有共同的有氧糖酵解表型。通过激活低氧诱导因子(HIF),有氧糖酵解增强,细胞增殖被触发。除了谷氨酰胺代谢外,兰德尔循环也存在于PAH中。增强的谷氨酰胺代谢补充了糖酵解所使用的碳中间体,并为过度增殖和抗凋亡的肺血管细胞提供能量。通过激活兰德尔循环,有氧氧化增强,三磷酸腺苷(ATP)增加,心肌损伤减轻。PAH由DNA甲基化、组蛋白乙酰化和微小RNA的表观遗传失调引发。本文讨论了PAH的异常代谢以及如何利用代谢疗法对抗重塑。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c37c/9458918/8d4f57d0f924/fcvm-09-957524-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c37c/9458918/8d4f57d0f924/fcvm-09-957524-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c37c/9458918/8d4f57d0f924/fcvm-09-957524-g0001.jpg

相似文献

1
Metabolic reprogramming: A novel metabolic model for pulmonary hypertension.代谢重编程:一种用于肺动脉高压的新型代谢模型。
Front Cardiovasc Med. 2022 Aug 26;9:957524. doi: 10.3389/fcvm.2022.957524. eCollection 2022.
2
Metabolism and bioenergetics in the right ventricle and pulmonary vasculature in pulmonary hypertension.肺动脉高压右心和肺血管的代谢和生物能量学。
Pulm Circ. 2013 Jan;3(1):144-52. doi: 10.4103/2045-8932.109960.
3
Functions and novel regulatory mechanisms of key glycolytic enzymes in pulmonary arterial hypertension.肺动脉高压中关键糖酵解酶的功能和新的调节机制。
Eur J Pharmacol. 2024 May 5;970:176492. doi: 10.1016/j.ejphar.2024.176492. Epub 2024 Mar 19.
4
Identification of MicroRNA-124 as a Major Regulator of Enhanced Endothelial Cell Glycolysis in Pulmonary Arterial Hypertension via PTBP1 (Polypyrimidine Tract Binding Protein) and Pyruvate Kinase M2.通过PTBP1(多嘧啶序列结合蛋白)和丙酮酸激酶M2鉴定MicroRNA-124作为肺动脉高压中内皮细胞糖酵解增强的主要调节因子。
Circulation. 2017 Dec 19;136(25):2451-2467. doi: 10.1161/CIRCULATIONAHA.117.028034. Epub 2017 Sep 26.
5
Osthole alleviates pulmonary vascular remodeling by modulating microRNA-22-3p mediated lipid metabolic reprogramming.蛇床子素通过调节 microRNA-22-3p 介导的脂质代谢重编程减轻肺血管重构。
Phytomedicine. 2022 Feb;96:153840. doi: 10.1016/j.phymed.2021.153840. Epub 2021 Nov 6.
6
Metabolic Reprogramming and Redox Signaling in Pulmonary Hypertension.肺动脉高压中的代谢重编程与氧化还原信号传导
Adv Exp Med Biol. 2017;967:241-260. doi: 10.1007/978-3-319-63245-2_14.
7
Platelet glycolytic metabolism correlates with hemodynamic severity in pulmonary arterial hypertension.血小板糖酵解代谢与肺动脉高压的血液动力学严重程度相关。
Am J Physiol Lung Cell Mol Physiol. 2020 Mar 1;318(3):L562-L569. doi: 10.1152/ajplung.00389.2019. Epub 2020 Feb 5.
8
Mammalian target of rapamycin complex 2 (mTORC2) coordinates pulmonary artery smooth muscle cell metabolism, proliferation, and survival in pulmonary arterial hypertension.哺乳动物雷帕霉素靶蛋白复合物 2(mTORC2)协调肺动脉平滑肌细胞代谢、增殖和在肺动脉高压中的存活。
Circulation. 2014 Feb 25;129(8):864-74. doi: 10.1161/CIRCULATIONAHA.113.004581. Epub 2013 Nov 22.
9
Oxygen sensing, mitochondrial biology and experimental therapeutics for pulmonary hypertension and cancer.氧感知、线粒体生物学与肺动脉高压和癌症的实验治疗。
Free Radic Biol Med. 2021 Jul;170:150-178. doi: 10.1016/j.freeradbiomed.2020.12.452. Epub 2021 Jan 12.
10
ALDH1A3 Coordinates Metabolism With Gene Regulation in Pulmonary Arterial Hypertension.醛脱氢酶1A3在肺动脉高压中协调代谢与基因调控。
Circulation. 2021 May 25;143(21):2074-2090. doi: 10.1161/CIRCULATIONAHA.120.048845. Epub 2021 Mar 25.

引用本文的文献

1
C-type natriuretic peptide attenuates enhanced glycolysis and de novo pyrimidine synthesis in pericytes of patients with pulmonary arterial hypertension.C型利钠肽减轻肺动脉高压患者周细胞中糖酵解增强和从头嘧啶合成。
Commun Biol. 2025 Aug 12;8(1):1199. doi: 10.1038/s42003-025-08661-0.
2
The mitochondrial unfolded protein response and metabolic reprogramming promote PASMC proliferation in response to sphingosine kinase-1/sphingosine-1-phosphate signaling.线粒体未折叠蛋白反应和代谢重编程通过鞘氨醇激酶-1/鞘氨醇-1-磷酸信号促进肺动脉平滑肌细胞增殖。
bioRxiv. 2025 Jun 11:2025.06.10.658872. doi: 10.1101/2025.06.10.658872.
3

本文引用的文献

1
Systems-level regulation of microRNA networks by miR-130/301 promotes pulmonary hypertension.由miR-130/301介导的微小RNA网络的系统水平调控促进肺动脉高压。
J Clin Invest. 2022 May 16;132(10). doi: 10.1172/JCI161077.
2
PARP1-PKM2 Axis Mediates Right Ventricular Failure Associated With Pulmonary Arterial Hypertension.PARP1-PKM2轴介导与肺动脉高压相关的右心室衰竭。
JACC Basic Transl Sci. 2022 Mar 16;7(4):384-403. doi: 10.1016/j.jacbts.2022.01.005. eCollection 2022 Apr.
3
Implication of proliferation gene biomarkers in pulmonary hypertension.
Restoration of pp60 Re-Establishes Electron Transport Chain Complex I Activity in Pulmonary Hypertensive Endothelial Cells.
pp60的恢复可重新建立肺动脉高压内皮细胞中的电子传递链复合体I活性。
Int J Mol Sci. 2025 Apr 17;26(8):3815. doi: 10.3390/ijms26083815.
4
Oroxylin A, a broad‑spectrum anticancer agent, relieves monocrotaline‑induced pulmonary arterial hypertension by inhibiting the Warburg effect in rats.盐酸小檗碱 A 是一种广谱抗癌药物,通过抑制大鼠的瓦博格效应缓解野百合碱诱导的肺动脉高压。
Mol Med Rep. 2024 Nov;30(5). doi: 10.3892/mmr.2024.13319. Epub 2024 Sep 2.
5
Glycolysis Reprogramming in Idiopathic Pulmonary Fibrosis: Unveiling the Mystery of Lactate in the Lung.特发性肺纤维化中的糖酵解重编程:揭示肺中乳酸的奥秘。
Int J Mol Sci. 2023 Dec 25;25(1):315. doi: 10.3390/ijms25010315.
增殖基因生物标志物在肺动脉高压中的意义。
Animal Model Exp Med. 2021 Nov 22;4(4):369-380. doi: 10.1002/ame2.12191. eCollection 2021 Dec.
4
Plasma metabolomics in the perioperative period of defect repair in patients with pulmonary arterial hypertension associated with congenital heart disease.先天性心脏病相关肺动脉高压患者缺陷修复围手术期的血浆代谢组学。
Acta Pharmacol Sin. 2022 Jul;43(7):1710-1720. doi: 10.1038/s41401-021-00804-3. Epub 2021 Nov 30.
5
Identification of Hypoxia Induced Metabolism Associated Genes in Pulmonary Hypertension.肺动脉高压中缺氧诱导的代谢相关基因的鉴定
Front Pharmacol. 2021 Nov 5;12:753727. doi: 10.3389/fphar.2021.753727. eCollection 2021.
6
The Emerging Role of Fatty Acid Synthase in Hypoxia-Induced Pulmonary Hypertensive Mouse Energy Metabolism.脂肪酸合酶在缺氧诱导的肺动脉高压小鼠能量代谢中的新作用
Oxid Med Cell Longev. 2021 Aug 17;2021:9990794. doi: 10.1155/2021/9990794. eCollection 2021.
7
Glutaminolysis: A Driver of Vascular and Cardiac Remodeling in Pulmonary Arterial Hypertension.谷氨酰胺分解:肺动脉高压中血管和心脏重塑的驱动因素
Front Cardiovasc Med. 2021 Apr 28;8:667446. doi: 10.3389/fcvm.2021.667446. eCollection 2021.
8
R-Crizotinib predisposes to and exacerbates pulmonary arterial hypertension in animal models.R-克唑替尼在动物模型中易引发并加重肺动脉高压。
Eur Respir J. 2021 May 13;57(5). doi: 10.1183/13993003.03271-2020. Print 2021 May.
9
DNA methyltransferase 3B deficiency unveils a new pathological mechanism of pulmonary hypertension.DNA 甲基转移酶 3B 缺乏揭示了肺动脉高压的一种新病理机制。
Sci Adv. 2020 Dec 9;6(50). doi: 10.1126/sciadv.aba2470. Print 2020 Dec.
10
Perivascular Inflammation in Pulmonary Arterial Hypertension.肺高血压中的血管周围炎症。
Cells. 2020 Oct 22;9(11):2338. doi: 10.3390/cells9112338.